borderline significantp = 0.058
Viability was significantly reduced upon adding cisplatin at the IC 50 of the corresponding sensitive cell lines, ranging from 14% ( p = 0.012) to 18% ( p = 0.014) in NCCIT-R cells, and from 15% ( p = 0.019) to a borderline significant 13% ( p = 0.058) in 2102Ep-R cells for immediate and delayed sequencing, respectively.